Don did say in the PBA presentation that they had about 600kg of finished product that was in Europe and Michigan. That supply was what he hopes sell at first opportunity and was the basis for his hope to generate some revenue based upon pre approval purchases by jurisdictions hoping to be at the front of the que should approval come. 

Eversana looks like a well qualified distribution partner but to me this is just more talk from a big talker until the trial gets underway. The response to Drago re commencement of the trial certainly doesn't instill confidence that they will hit the June 12 target as per clinicaltrials.gov. 

To me it is almost unbelievable that management going "hardcore" has been so slow on all of this.  They started talking about COVID in March 2020, the basis for the Cell publication was submitted to Cell in October 2020 so the company has known about those results for roughly 8 months, in February Don said trial enrolment could start in March but might "slip into April" and that we could "have data as early as May", now they are using wiggle words on the June 12 trial start.  All he has to show is a distribution deal, what has changed since he has done all this talking?